Cargando…

Mammary stem cell number as a determinate of breast cancer risk

The 'cancer stem cell hypothesis' posits that cancers, including breast cancer, arise in tissue stem or progenitor cells. If this is the case, then it follows that the risk for developing breast cancer may be determined in part by the number of breast stem/progenitor cells that can serve a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ginestier, Christophe, Wicha, Max S
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206714/
https://www.ncbi.nlm.nih.gov/pubmed/17688678
http://dx.doi.org/10.1186/bcr1741
_version_ 1782148496516710400
author Ginestier, Christophe
Wicha, Max S
author_facet Ginestier, Christophe
Wicha, Max S
author_sort Ginestier, Christophe
collection PubMed
description The 'cancer stem cell hypothesis' posits that cancers, including breast cancer, arise in tissue stem or progenitor cells. If this is the case, then it follows that the risk for developing breast cancer may be determined in part by the number of breast stem/progenitor cells that can serve as targets for transformation. Stem cell number may be set during critical windows of development, including in utero, adolescence, and pregnancy. The growth hormone/insulin-like growth factor-1 axis may play an important role in regulating breast stem cell number during these developmental windows, suggesting an important link between this signaling pathway and breast cancer risk.
format Text
id pubmed-2206714
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-22067142008-01-19 Mammary stem cell number as a determinate of breast cancer risk Ginestier, Christophe Wicha, Max S Breast Cancer Res Editorial The 'cancer stem cell hypothesis' posits that cancers, including breast cancer, arise in tissue stem or progenitor cells. If this is the case, then it follows that the risk for developing breast cancer may be determined in part by the number of breast stem/progenitor cells that can serve as targets for transformation. Stem cell number may be set during critical windows of development, including in utero, adolescence, and pregnancy. The growth hormone/insulin-like growth factor-1 axis may play an important role in regulating breast stem cell number during these developmental windows, suggesting an important link between this signaling pathway and breast cancer risk. BioMed Central 2007 2007-07-31 /pmc/articles/PMC2206714/ /pubmed/17688678 http://dx.doi.org/10.1186/bcr1741 Text en Copyright © 2007 BioMed Central Ltd
spellingShingle Editorial
Ginestier, Christophe
Wicha, Max S
Mammary stem cell number as a determinate of breast cancer risk
title Mammary stem cell number as a determinate of breast cancer risk
title_full Mammary stem cell number as a determinate of breast cancer risk
title_fullStr Mammary stem cell number as a determinate of breast cancer risk
title_full_unstemmed Mammary stem cell number as a determinate of breast cancer risk
title_short Mammary stem cell number as a determinate of breast cancer risk
title_sort mammary stem cell number as a determinate of breast cancer risk
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206714/
https://www.ncbi.nlm.nih.gov/pubmed/17688678
http://dx.doi.org/10.1186/bcr1741
work_keys_str_mv AT ginestierchristophe mammarystemcellnumberasadeterminateofbreastcancerrisk
AT wichamaxs mammarystemcellnumberasadeterminateofbreastcancerrisk